<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25-cells-09-00031">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Matthys</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>McGuire</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wire</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Bowen</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Jenkins</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Clinical pharmacokinetics, platelet response, and safety of eltrombopag at supratherapeutic doses of up to 200 mg once daily in healthy volunteers</article-title>
  <source>J. Clin. Pharmacol.</source>
  <year>2011</year>
  <volume>51</volume>
  <fpage>301</fpage>
  <lpage>308</lpage>
  <pub-id pub-id-type="doi">10.1177/0091270010368677</pub-id>
  <pub-id pub-id-type="pmid">20418510</pub-id>
 </element-citation>
</ref>
